IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target

Overview

Journal Antibodies (Basel)

Date 2020 Dec 11

PMID 33302566

Citations 3

Authors

Yasmine Lamri

Nicolas Charles

Affiliations

Soon will be listed here.

Abstract

Systemic lupus erythematosus (SLE) is a multifactorial chronic autoimmune disease, marked by the presence of autoantibodies to nuclear antigens belonging to different isotype classes. For several years, IgE antibodies have been incriminated in the development of allergic diseases and parasitic infections and different anti-IgE therapies have been developed to encounter the pathogenic role of IgE in these pathologies. Recently, multiple studies showed the presence of elevated total IgE levels and demonstrated a pathogenic role of autoreactive IgE in SLE. This review aims to summarize the findings incriminating IgE and autoreactive IgE in the pathophysiology of SLE, to describe their functional outcomes on their targeted cells as well as to discuss different IgE-related therapeutic modalities that emerged and that may be beneficial for SLE patient care.

Citing Articles

Clinical manifestations in patients with anti-IFN-γ autoantibodies syndrome and Talaromyces marneffei infection: a prospective cohort study.

Liang H, Liang S, Wu S, Chen N, Huang X, Zeng Q BMC Infect Dis. 2025; 25(1):268.

PMID: 40000959 PMC: 11853739. DOI: 10.1186/s12879-025-10690-3.

Progressively differentiated T13 cells are stabilized by JunB to mediate allergen germinal center responses.

Chandrakar P, Nelson C, Podesta M, Cavazzoni C, Gempler M, Lee J Nat Immunol. 2025; 26(3):473-483.

PMID: 39891019 DOI: 10.1038/s41590-025-02077-y.

Anti-dsDNA IgE: a potential non-invasive test for prediction of lupus nephritis relapse.

Himbert M, Jourde-Chiche N, Chapart L, Charles N, Baumstarck K, Daugas E RMD Open. 2024; 10(2).

PMID: 38942591 PMC: 11227839. DOI: 10.1136/rmdopen-2024-004255.

Behind the scenes with basophils: an emerging therapeutic target.

Shah H, Eisenbarth S, Tormey C, Siddon A Immunother Adv. 2022; 1(1):ltab008.

PMID: 35919744 PMC: 9327101. DOI: 10.1093/immadv/ltab008.

Infection Is Associated With an Increased Risk of Systemic Lupus Erythematosus: A Nationwide, Retrospective Cohort Study.

Chu K, Ou T, Hung W, Sung J, Chen W, Lin C Front Microbiol. 2022; 13:815136.

PMID: 35531287 PMC: 9069054. DOI: 10.3389/fmicb.2022.815136.

References

Cassard L, Jonsson F, Arnaud S, Daeron M . Fcγ receptors inhibit mouse and human basophil activation. J Immunol. 2012; 189(6):2995-3006. DOI: 10.4049/jimmunol.1200968. View

Henault J, Riggs J, Karnell J, Liarski V, Li J, Shirinian L . Self-reactive IgE exacerbates interferon responses associated with autoimmunity. Nat Immunol. 2015; 17(2):196-203. PMC: 4718782. DOI: 10.1038/ni.3326. View

Linge P, Fortin P, Lood C, Bengtsson A, Boilard E . The non-haemostatic role of platelets in systemic lupus erythematosus. Nat Rev Rheumatol. 2018; 14(4):195-213. DOI: 10.1038/nrrheum.2018.38. View

Logsdon S, Oettgen H . Anti-IgE therapy: clinical utility and mechanistic insights. Curr Top Microbiol Immunol. 2015; 388:39-61. DOI: 10.1007/978-3-319-13725-4_3. View

Harris J, Maciuca R, Bradley M, Cabanski C, Scheerens H, Lim J . A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma. Respir Res. 2016; 17:29. PMC: 4797126. DOI: 10.1186/s12931-016-0347-2. View

Atta A, Sousa C, Carvalho E, Sousa-Atta M . Immunoglobulin E and systemic lupus erythematosus. Braz J Med Biol Res. 2004; 37(10):1497-501. DOI: 10.1590/s0100-879x2004001000008. View

De Bandt M . Anti-TNF-alpha-induced lupus. Arthritis Res Ther. 2019; 21(1):235. PMC: 6852950. DOI: 10.1186/s13075-019-2028-2. View

Yin X, Yu H, Jin X, Li J, Guo H, Shi Q . Human Blood CD1c+ Dendritic Cells Encompass CD5high and CD5low Subsets That Differ Significantly in Phenotype, Gene Expression, and Functions. J Immunol. 2017; 198(4):1553-1564. DOI: 10.4049/jimmunol.1600193. View

Egido J, Sanchez Crespo M, Lahoz C, Garcia R, Lopez-Trascasa M, Hernando L . Evidence of an immediate hypersensitivity mechanism in systemic lupus erythematosus. Ann Rheum Dis. 1980; 39(4):312-7. PMC: 1000548. DOI: 10.1136/ard.39.4.312. View

10.

Malbec O, Cassard L, Albanesi M, Jonsson F, Mancardi D, Chicanne G . Trans-inhibition of activation and proliferation signals by Fc receptors in mast cells and basophils. Sci Signal. 2016; 9(459):ra126. DOI: 10.1126/scisignal.aag1401. View

11.

Hiromura K, Kurosawa M, Yano S, Naruse T . Tubulointerstitial mast cell infiltration in glomerulonephritis. Am J Kidney Dis. 1998; 32(4):593-9. DOI: 10.1016/s0272-6386(98)70022-8. View

12.

James K, Peebles Jr R, Hartert T . Response to infections in patients with asthma and atopic disease: an epiphenomenon or reflection of host susceptibility?. J Allergy Clin Immunol. 2012; 130(2):343-51. PMC: 3410318. DOI: 10.1016/j.jaci.2012.05.056. View

13.

Gasser P, Tarchevskaya S, Guntern P, Brigger D, Ruppli R, Zbaren N . The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab. Nat Commun. 2020; 11(1):165. PMC: 6949303. DOI: 10.1038/s41467-019-13815-w. View

14.

Danilewicz M, Wagrowska-Danilewicz M . Quantitative analysis of interstitial mast cells in lupus and non-lupus membranous glomerulopathy. Pol J Pathol. 2002; 52(4):211-7. View

15.

Parks C, Biagini R, Cooper G, Gilkeson G, Dooley M . Total serum IgE levels in systemic lupus erythematosus and associations with childhood onset allergies. Lupus. 2010; 19(14):1614-22. DOI: 10.1177/0961203310379870. View

16.

Orengo J, Radin A, Kamat V, Badithe A, Ben L, Bennett B . Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement. Nat Commun. 2018; 9(1):1421. PMC: 5897525. DOI: 10.1038/s41467-018-03636-8. View

17.

Charles N, Watford W, Ramos H, Hellman L, Oettgen H, Gomez G . Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation. Immunity. 2009; 30(4):533-43. PMC: 2772996. DOI: 10.1016/j.immuni.2009.02.008. View

18.

Laurent J, LAGRUE G, Sobel A . Increased serum IgE levels in patients with lupus nephritis. Am J Nephrol. 1986; 6(5):413-4. DOI: 10.1159/000167202. View

19.

Kato Y, Park J, Takamatsu H, Konaka H, Aoki W, Aburaya S . Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus. Ann Rheum Dis. 2018; 77(10):1507-1515. PMC: 6161667. DOI: 10.1136/annrheumdis-2018-212988. View

20.

van Nieuwenhuijze A, Cauwe B, Klatt D, Humblet-Baron S, Liston A . Lpr-induced systemic autoimmunity is unaffected by mast cell deficiency. Immunol Cell Biol. 2015; 93(10):841-8. DOI: 10.1038/icb.2015.49. View